Khazami pour, Nastaran
$150,000.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2016-2017
Canada
Combination of a unique parasite-derived chondroitin sulfate targeting-approach with state-of-the art cancer immune therapy technology to target cancer.